Absolute CD4 count and percentage values among Libyan patients with HIV by single-platform flow cytometry.

CD4 CD8 HIV Libya flow cytometry single platform

Journal

Laboratory medicine
ISSN: 1943-7730
Titre abrégé: Lab Med
Pays: England
ID NLM: 0250641

Informations de publication

Date de publication:
21 Jun 2024
Historique:
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 21 6 2024
Statut: aheadofprint

Résumé

Single-platform flow cytometry technology together with CD45-gating is becoming the method of choice for absolute CD4 T cell enumeration. Immunological assessment of HIV patients by monitoring CD4 can provide valuable information on antiviral treatment response and disease progression. A total of 97 HIV-positive individuals were recruited from 2 hospitals in Tripoli, Libya, and 14 healthy blood donors. The HIV-infected individuals were classified by CD4+ count into HIV-positive (>200 cells/µL) or AIDS (≤200 cells/µL) groups. CD4+ and CD8+ cell counts were determined and compared among the groups and with similar published data. The mean ± SD CD4+ cell counts were 1106 ± 442.8 cells/µL in healthy individuals, 460 ± 219.7 cells/µL in the HIV-positive group, and 78 ± 64.3 cells/µL in the AIDS group. The mean ± SD CD4+/CD8+ ratio was 1.6 ± 0.58, 0.4 ± 0.22, and 0.1 ± 0.1, respectively. CD4+ counts in Libyan healthy adults might be higher than those reported in several studies in other regions, whereas CD4+ counts in Libyan AIDS patients seem lower. Reference values for T lymphocyte counts in Libyan healthy individuals should be investigated more extensively, and the reasons why Libyan AIDS patients seem to have such lower CD4+ counts should be examined.

Sections du résumé

BACKGROUND BACKGROUND
Single-platform flow cytometry technology together with CD45-gating is becoming the method of choice for absolute CD4 T cell enumeration. Immunological assessment of HIV patients by monitoring CD4 can provide valuable information on antiviral treatment response and disease progression.
METHODS METHODS
A total of 97 HIV-positive individuals were recruited from 2 hospitals in Tripoli, Libya, and 14 healthy blood donors. The HIV-infected individuals were classified by CD4+ count into HIV-positive (>200 cells/µL) or AIDS (≤200 cells/µL) groups. CD4+ and CD8+ cell counts were determined and compared among the groups and with similar published data.
RESULTS RESULTS
The mean ± SD CD4+ cell counts were 1106 ± 442.8 cells/µL in healthy individuals, 460 ± 219.7 cells/µL in the HIV-positive group, and 78 ± 64.3 cells/µL in the AIDS group. The mean ± SD CD4+/CD8+ ratio was 1.6 ± 0.58, 0.4 ± 0.22, and 0.1 ± 0.1, respectively. CD4+ counts in Libyan healthy adults might be higher than those reported in several studies in other regions, whereas CD4+ counts in Libyan AIDS patients seem lower.
CONCLUSION CONCLUSIONS
Reference values for T lymphocyte counts in Libyan healthy individuals should be investigated more extensively, and the reasons why Libyan AIDS patients seem to have such lower CD4+ counts should be examined.

Identifiants

pubmed: 38902933
pii: 7696818
doi: 10.1093/labmed/lmae046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Yosra Lamami (Y)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Abdulmunem M Abulayha (AM)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Salah Altabal (S)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Mohamed Elbasir (M)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Abdulrhman S Elbnnani (AS)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Laila Aghil (L)

National Center for Disease Control, Tripoli, Libya.

Fawzi Ebrahim (F)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Adam Elzagheid (A)

Libyan Biotechnology Research Center, Department of Human Cells and Tissues, Tripoli, Libya.

Classifications MeSH